HYPOFRACTIONATED EXTERNAL BEAM RADIATION WITH BEVACIZUMAB FOR THE TREATMENT OF RECURRENT HIGH GRADE GLIOMA - REPORT OF TWO CASES

被引：0
|
作者：
Gilheeney, S. W. [1 ]
Wolden, S. [1 ]
Dunkel, I. J. [1 ]
Khakoo, Y. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
NEURO-ONCOLOGY | 2010年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：II74 / II74
页数：1
相关论文
共 50 条
  • [31] NOONAN SYNDROME CAN BE ASSOCIATED WITH HIGH GRADE GLIOMA; A REPORT OF TWO CASES
    El-Ayadi, Moatasem
    Ansari, Marc
    Kuehnoel, Caspar
    Bendel, Anne
    Sturm, Dominik
    Pietsch, Torsten
    Kramm, Christof
    von Bueren, Andre
    NEURO-ONCOLOGY, 2017, 19 : 72 - 72
  • [32] A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (NCT02313272)
    Sahebjam, Solmaz
    Forsyth, Peter
    Arrington, John
    Jaglal, Michael
    Tran, Nam D.
    Etame, Arnold B.
    Wicklund, Melissa
    Drury-Sibiga, Ali
    Long, Wendy
    Evernden, Brittany
    Gatewood, Tyra
    Macaulay, Robert
    Chinnaiyan, Prakash
    Yu, Michael
    NEURO-ONCOLOGY, 2017, 19 : 30 - 30
  • [33] A Pilot Study of Hypofractionated Stereotactic Radiation Therapy and Sunitinib in Previously Irradiated Patients With Recurrent High-Grade Glioma
    Wuthrick, Evan J.
    Curran, Walter J., Jr.
    Camphausen, Kevin
    Lin, Alexander
    Glass, Jon
    Evans, James
    Andrews, David W.
    Axelrod, Rita
    Shi, Wenyin
    Werner-Wasik, Maria
    Haacke, E. Mark
    Hillman, Gilda G.
    Dicker, Adam P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (02): : 369 - 375
  • [34] OUTCOMES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA (HGG) TREATED WITH BEVACIZUMAB
    Ye, L.
    Hasani, A.
    Nowak, A.
    King, A.
    Long, A.
    Trevenen, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 72 - 72
  • [35] Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma
    Smith, Katrina H.
    Lee, Eudocia Quant
    Muzikansky, Alona
    Robins, Elizabeth
    Duda, Gerstner Dan G.
    Reardon, David A.
    Nayak, Lakshmi
    Norden, Andrew David
    Doherty, Lisa M.
    Rifenburg, Jennifer
    LaFrankie, Debra C.
    Ruland, Sandra
    Pulverenti, Julee
    Stokes, Deirdre
    Lam, Priscilla
    McCluskey, Christine Sceppa
    Gaffey, Sarah C.
    Batchelor, Tracy
    Jain, Ftakesh K.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma
    Abrams, Daniela Alexandru
    Hanson, Joseph A.
    Brown, Justin M.
    Hsu, Frank P. K.
    Delashaw, Johnny B., Jr.
    Bota, Daniela A.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (01) : 35 - 39
  • [37] Bevacizumab Use for Recurrent High-Grade Glioma at McGill University Hospital
    Sahebjam, Solmaz
    Garoufalis, Evgenia
    Guiot, Marie-Christine
    Muanza, Thierry
    Del Maestro, Rolando
    Petrecca, Kevin
    Sharma, Rajesh
    Kavan, Petr
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2013, 40 (02) : 241 - 246
  • [38] Bevacizumab therapy in recurrent high grade glioma: Impact on local control and survival
    Narayana, A.
    Raza, S.
    Golfinos, J. G.
    Johnson, G.
    Knopp, E. A.
    Zagzag, D.
    Fischer, I.
    Medabalmi, P.
    Eagan, P.
    Gruber, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Hypofractionated stereotactic radiosurgery (HSRS) in recurrent high grade glioma: A safe and effective approach
    Navarria, P.
    Ascolese, A. M.
    Villa, E.
    Clerici, E.
    Bello, L.
    Pessina, F.
    Stravato, A.
    Mancosu, P.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S9 - S9
  • [40] Combining metronomic dose temozolomide with bevacizumab in recurrent high grade glioma patients
    Verhoeff, Joost
    van Linde, Myra
    Lavini, Cristina
    Reineveld, Jaap
    Stalpers, Lukas
    Majoie, Charles
    van Furth, Wouter
    Richel, Dirk
    CANCER RESEARCH, 2008, 68 (09)
12345